Monthly Archives: August 2022

(1) Abbreviated Excerpt:  ”Most breast cancer cases show low concentrations of the breast cancer type 1 susceptibility protein (BRCA1). Surprisingly, only a small number of these patients have a mutated BRCA1 gene. Studies estimated that BRCA1 and BRCA2 mutations account … Continue reading →

Bierhansl, L., Hartung, HP., Aktas, O. et al. Thinking outside the box: non-canonical targets in multiple sclerosis. Nat Rev Drug Discov 21, 578–600 (2022). https://doi.org/10.1038/s41573-022-00477-5 https://www.nature.com/articles/s41573-022-00477-5

Abstract: “Healthspan is the period of our life without major debilitating diseases. In the modern world where unhealthy lifestyle choices and chronic diseases taper the healthspan, which lead to an enormous economic burden, finding ways to promote healthspan becomes a … Continue reading →